Literature DB >> 12948285

Heterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands).

Daphne L van der A1, Olga van der Hel, Mark Roest, Yvonne T van der Schouw, Carla H van Gils, Joannes J M Marx, Paulus A H van Noord, Petra H M Peeters.   

Abstract

BACKGROUND & AIMS: Heterozygosity for the Cys282Tyr transition in the HFE-gene is associated with slightly increased iron levels and may therefore be a potential risk factor for colorectal cancer.
METHODS: We studied the relationship between Cys282Tyr-heterozygosity and colorectal cancer using a case-control design. The 240 colorectal cancer cases and 635 controls in our study were derived from a prospective cohort study of 12,242 postmenopausal women, who were invited for an experimental breast cancer screening program in Utrecht, The Netherlands. The women were age 51-69 at time of inclusion and were followed for a period of 20 years. HFE genotyping was performed by PCR and allele-specific oligonucleotide (ASO) hybridization.
RESULTS: The risk of colorectal cancer was higher for women who were heterozygous for the Cys282Tyr mutation, than for those who were Cys282Tyr-wildtypes, although this was not statistically significant (Age-adjusted OR = 1.2, 95% CI: 0.6-2.2). Cys282Tyr-heterozygotes who smoked seemed to be at higher risk of colorectal cancer, although the p-value for interaction was not significant (p-value 0.42).
CONCLUSIONS: The Cys282Tyr mutation is not associated with an increased risk for colorectal cancer in postmenopausal women, although in combination with smoking a slightly increased risk cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948285     DOI: 10.1023/a:1024839528684

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  10 in total

1.  Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Amanda J Cross; Rashmi Sinha; Richard J Wood; Xiaonan Xue; Wen-Yi Huang; Meredith Yeager; Richard B Hayes; Marc J Gunter
Journal:  Cancer Prev Res (Phila)       Date:  2011-06-17

2.  HFE gene C282Y variant is associated with colorectal cancer in Caucasians: a meta-analysis.

Authors:  Weidong Chen; Hua Zhao; Tiegang Li; Hongliang Yao
Journal:  Tumour Biol       Date:  2013-04-04

3.  Gender and plasma iron biomarkers, but not HFE gene mutations, increase the risk of colorectal cancer and polyps.

Authors:  Agustin Castiella; Fernando Múgica; Eva Zapata; Leire Zubiaurre; Arantxa Iribarren; M Dolores de Juan; Luis Alzate; Ines Gil; Gregorio Urdapilleta; Pedro Otazua; José Ignacio Emparanza
Journal:  Tumour Biol       Date:  2015-04-09

4.  Iron: an emerging factor in colorectal carcinogenesis.

Authors:  Anita C G Chua; Borut Klopcic; Ian C Lawrance; John K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

5.  HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.

Authors:  Nicholas J Osborne; Lyle C Gurrin; Katrina J Allen; Clare C Constantine; Martin B Delatycki; Christine E McLaren; Dorota M Gertig; Gregory J Anderson; Melissa C Southey; John K Olynyk; Lawrie W Powell; John L Hopper; Graham G Giles; Dallas R English
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

6.  Dietary iron, iron homeostatic gene polymorphisms and the risk of advanced colorectal adenoma and cancer.

Authors:  Elizabeth H Ruder; Sonja I Berndt; Anne M J Gilsing; Barry I Graubard; Laurie Burdett; Richard B Hayes; Joel L Weissfeld; Leah M Ferrucci; Rashmi Sinha; Amanda J Cross
Journal:  Carcinogenesis       Date:  2014-02-17       Impact factor: 4.944

7.  HFE H63D mutation frequency shows an increase in Turkish women with breast cancer.

Authors:  Aysen Gunel-Ozcan; Sibel Alyilmaz-Bekmez; Emine Nilufer Guler; Dicle Guc
Journal:  BMC Cancer       Date:  2006-02-19       Impact factor: 4.430

8.  Association Studies of HFE C282Y and H63D Variants with Oral Cancer Risk and Iron Homeostasis Among Whites and Blacks.

Authors:  Nathan R Jones; Joseph H Ashmore; Sang Y Lee; John P Richie; Philip Lazarus; Joshua E Muscat
Journal:  Cancers (Basel)       Date:  2015-12-09       Impact factor: 6.639

9.  The risk of new-onset cancer associated with HFE C282Y and H63D mutations: evidence from 87,028 participants.

Authors:  Yang-Fan Lv; Xian Chang; Rui-Xi Hua; Guang-Ning Yan; Gang Meng; Xiao-Yu Liao; Xi Zhang; Qiao-Nan Guo
Journal:  J Cell Mol Med       Date:  2016-02-19       Impact factor: 5.310

10.  Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Antonio Agudo; Catalina Bonet; Núria Sala; Xavier Muñoz; Núria Aranda; Ana Fonseca-Nunes; Françoise Clavel-Chapelon; Marie Christine Boutron-Ruault; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Sara Grioni; J Ramón Quirós; Esther Molina; Carmen Navarro; Aurelio Barricarte; Saioa Chamosa; Naomi E Allen; Kay-Tee Khaw; H Bas Bueno-de-Mesquita; Peter D Siersema; Mattijs E Numans; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Rudof Kaaks; Federico Canzian; Heiner Boeing; Karina Meidtner; Mattias Johansson; Malin Sund; Jonas Manjer; Kim Overvad; Anne Tjonneland; Eiliv Lund; Elisabete Weiderpass; Mazda Jenab; Veronika Fedirko; G Johan A Offerhaus; Elio Riboli; Carlos A González; Paula Jakszyn
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.